nfr-logonfr-logo
PROJECT BANK
Switch to English
Statistics
Projects

0 projects

Date from new to old

EIC-The European Innovation Council (EIC)

NEXT GENERATION IMAGING FOR REAL-TIME DOSE VERIFICATION ENABLING ADAPTIVE PROTON THERAPY

NEXT GENERATION IMAGING FOR REAL-TIME DOSE VERIFICATION ENABLING ADAPTIVE PROTON THERAPY

Awarded: NOK 17.8 mill.

Project Period: 2024-2028

Location: Vestland

EIC-The European Innovation Council (EIC)

Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis.

Deep-lying cancers, such as glioblastoma multiforme (GBM) brain cancer, are very difficult to access and incurable by the current standards of care. The fluorescence of photosensitive molecules (PSs) can precisely guide surgical resection of GBM. Nevertheless, photomedical treatments like photody...

Awarded: NOK 25.2 mill.

Project Period: 2024-2028

Location: Oslo

CL1-Health

ENTEROVIRUS-LINKED TYPE 1 DIABETES EXPOSED -MECHANISMS AND PREVENTION

ENT1DEP aims to define causal links between infections and NCDs by focusing on enterovirus (EV) infections and type 1 diabetes (T1D), a robust association without proof of causality. Causality is addressed by a multidisciplinary, multi-layer approach, using in-vitro and in-vivo models, unique hum...

Awarded: NOK 7.3 mill.

Project Period: 2024-2027

Location: Oslo

MSCA-Marie Sklodowska-Curie Actions (MSCA)

Human - Centric Indoor Climate for Healthcare Facilities

Over 4 million hospital patients acquire a healthcare-associated infection (HAI) in the EU each year. Moreover, the global crisis of antimicrobial resistance means that HAI is posing an increasing cost and risk of mortality. There is clear evidence that airflow controls the dispersion and exposur...

Awarded: NOK 9.0 mill.

Project Period: 2024-2027

Location: Trøndelag - Trööndelage

MSCA-Marie Sklodowska-Curie Actions (MSCA)

DSTrain - Data Science Postdoctoral Training Programme

DSTrain - Data Science Postdoctoral Training Programme

Awarded: NOK 52.1 mill.

Project Period: 2024-2028

Location: Akershus og 12 andre

CL1-Health

e-health tools to promote Equality in Quality of Life for childhood to young adulthood cancer patients, survivors and their families - a PanEuropean project supported by PanCare and Harmonic consortia

Cancer affects 35,000 children, adolescents and young adults (CAYAC) in Europe each year. Current 5-year survival rates are 80%, but the intensive oncological treatments leave CAYAC Survivors (CAYACS) at increased risk of cancer or treatment-induced late health effects, excess morbidity and morta...

Awarded: NOK 5.5 mill.

Project Period: 2024-2027

Location: Oslo

CL1-Health

Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers

Perioperative care is an intricate process that encompasses 1) preoperative evaluation, surgical planning and preparation; 2) intraoperative procedure; and 3) postoperative management. Perioperative care depends on clinical decision-making, a continuous process that involves many healthcare profe...

Awarded: NOK 44.6 mill.

Project Period: 2024-2027

Location: Oslo og 2 andre

CL1-Health

The first European Digital Health Technology Assessment framework co-created by all stakeholders along the value chain

The first European Digital Health Technology Assessment framework co-created by all stakeholders along the value chain

Awarded: NOK 21.5 mill.

Project Period: 2024-2027

Location: Akershus og 2 andre

CL1-Health

The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomics

Adult and paediatric malignant glioma (GBM and pHGG) remain among the most difficult-to-treat cancers with 5-year survival rates of <5% despite intensive standard-of-care therapy. The differences among patients and the heterogeneous and plastic nature of each individual tumour have resulted in al...

Awarded: NOK 12.2 mill.

Project Period: 2024-2028

Location: Oslo

CL1-Health

Development of a global diagnostic ecosystem for detecting and monitoring emergency-prone pathogens across species and in a unified way

Development of a global diagnostic ecosystem for detecting and monitoring emergency-prone pathogens across species and in a unified way

Awarded: NOK 9.4 mill.

Project Period: 2023-2027

Location: Vestland

CL1-Health

Targeting Epstein-Barr Virus Infection for Treatment and Prevention of Multiple Sclerosis

Targeting Epstein-Barr Virus Infection for Treatment and Prevention of Multiple Sclerosis

Awarded: NOK 29.6 mill.

Project Period: 2023-2028

Location: Vestland og 5 andre

CL5-Climate, Energy and Mobility

From solar energy to fuel: A holistic artificial photosynthesis platform for the production of viable solar fuels

REFINE develops and demonstrates a system of artificial photosynthesis by combining both dark and light-dependent reactions for the direct production of high energy density and essential chemicals, such as alcohols. To achieve this, a direct hydrogen storage into hydrocarbons through CO2 capture ...

Awarded: NOK 21.8 mill.

Project Period: 2023-2027

Location: Oslo og 2 andre

CL1-Health

PREDICTION OF ALZHEIMER’S DISEASE USING AN AI DRIVEN SCREENING PLATFORM

PREDICTION OF ALZHEIMER’S DISEASE USING AN AI DRIVEN SCREENING PLATFORM

Awarded: NOK 11.9 mill.

Project Period: 2023-2027

Location: Rogaland

ERC-European Research Council (ERC)

Targeting Acute Leukemia with TdT-TCR-T-cell therapy

Targeting Acute Leukemia with TdT-TCR-T-cell therapy

Awarded: NOK 1.7 mill.

Project Period: 2023-2025

Location: Akershus og 2 andre

CL1-Health

PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials

PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials

Awarded: NOK 18.2 mill.

Project Period: 2023-2028

Location: Oslo

CL1-Health

Reconstruction and Computational Modelling for Inherited Metabolic Diseases

Our overall objectives are to accelerate the diagnosis, and enable personalised management, of inherited metabolic diseases (IMDs). Established academic technology for statistical genomic analysis, deep learning-based prediction of protein structure, and whole-body metabolic network modelling sha...

Awarded: NOK 0.10 mill.

Project Period: 2023-2027

Location: Oslo

CL1-Health

TOWARDS LARGE-SCALE ADAPTION AND TAILORED IMPLEMENTATION OF EVIDENCE-BASED PRIMARY CANCER PREVENTION PROGRAMMES IN EUROPE AND BEYOND

TOWARDS LARGE-SCALE ADAPTION AND TAILORED IMPLEMENTATION OF EVIDENCE-BASED PRIMARY CANCER PREVENTION PROGRAMMES IN EUROPE AND BEYOND

Awarded: NOK 1.8 mill.

Project Period: 2023-2027

Location: Vestland

CL1-Health

COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

Awarded: NOK 3.2 mill.

Project Period: 2023-2026

Location: Oslo

CL1-Health

IMPlementing geriatric assessment for dose Optimization of CDK 4/6-inhibitors in older bReasT cAncer patieNTs

IMPlementing geriatric assessment for dose Optimization of CDK 4/6-inhibitors in older bReasT cAncer patieNTs

Awarded: NOK 3.7 mill.

Project Period: 2023-2028

Location: Akershus

CL1-Health

International Study for Treatment of Childhood Relapsed ALL 2020

International Study for Treatment of Childhood Relapsed ALL 2020

Awarded: NOK 1.1 mill.

Project Period: 2023-2028

Location: Oslo

MSCA-Marie Sklodowska-Curie Actions (MSCA)

Guiding glioblastoma treatments by decrypting tumor biomechanics via Magnetic Resonance Elastography.

Guiding glioblastoma treatments by decrypting tumor biomechanics via Magnetic Resonance Elastography.

Awarded: NOK 2.9 mill.

Project Period: 2023-2026

Location: Oslo

CL1-Health

Establishing of Cancer Mission Hubs: Networks and Synergies

Cancer- healthcare, research and innovation face core common challenges, such as fragmentation of initiatives and distancing from important stakeholders, requiring coordinated solutions. These challenges are recognized in Horizon Europe’s Cancer Mission Implementation Plan and in Europe’s Beating...

Awarded: NOK 3.7 mill.

Project Period: 2023-2026

Location: Oslo og 3 andre

MSCA-Marie Sklodowska-Curie Actions (MSCA)

Combination therapy for the treatment of metastatic melanoma using magnetic nanoparticles

Metastatic melanoma is a hard-to-treat disease and it remains as one of the most worrisome cancer. There is an urgent need to improve the current therapies (chemotherapy, radiotherapy) that have a limited efficacy. A single therapy is not efficient to tackle metastatic melanoma and a combination ...

Awarded: NOK 3.0 mill.

Project Period: 2023-2027

Location: Oslo

ERC-European Research Council (ERC)

Final act of the autophagy symphony: Whole-organism orchestration of autophagy termination

Final act of the autophagy symphony: Whole-organism orchestration of autophagy termination

Awarded: NOK 15.2 mill.

Project Period: 2023-2027

Location: Oslo

MSCA-Marie Sklodowska-Curie Actions (MSCA)

Determining Genetic Bases of Differential Response to Antipsychotics Using Patient-Derived Neurons

Schizophrenia (SCZ) affects 20 million people worldwide and antipsychotics remain the only effective pharmacological intervention. However, one-third of people with SCZ do not respond to first-line antipsychotic drugs. In the absence of clinical biomarkers to stratify SCZ subtypes, all individual...

Awarded: NOK 3.1 mill.

Project Period: 2023-2025

Location: Vestland

WIDENING-Widening participation and spreading excellence

Diabetes, obesity and the Kidney

Diabetes, obesity and the Kidney

Awarded: NOK 2.9 mill.

Project Period: 2023-2025

Location: Oslo

CL1-Health

CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE

Rare tumour risk syndromes (RTRS) are rare diseases, affecting 5 per 10.000 people or less and caused by heritable genetic variants. In RTRS, the lifetime risk to develop various cancers can be as high as 100%, and patients have a 50% chance of transmitting the disease to their offspring. When un...

Awarded: NOK 3.5 mill.

Project Period: 2023-2025

Location: Vestland

CL1-Health

Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe

Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe

Awarded: NOK 7.6 mill.

Project Period: 2023-2026

Location: Oslo

CL1-Health

Maximising Impact of Prescription Drugs in Rheumatoid Arthritis

The SQUEEZE consortium comprehensively addressed how biomarkers can be used to optimize disease modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis (RA). RA is a chronic immune-mediated disease with enormous health-related quality of life and socioeconomic impact. A broad choice of DM...

Awarded: NOK 21.1 mill.

Project Period: 2022-2027

Location: Oslo

EIC-The European Innovation Council (EIC)

Supervised morphogenesis in gastruloids

Supervised morphogenesis in gastruloids

Awarded: NOK 13.6 mill.

Project Period: 2022-2027

Location: Oslo

12345